A Risk Sciences International news item (Last modifed: August 18, 2019)

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

Posted in

More RSI News

Aging and cognitive decline

September 21, 2023

Working with the College of Physicians and Surgeons of Alberta, Risk Sciences International conducted a wide-ranging review of aging and cognitive decline, with specific focus…

Read News Item

Evidence-based Risk Assessment Framework

December 12, 2022

Working with international thought leaders in risk science, Risk Sciences International investigators contributed to the development of the evidenced-based risk assessment framework shown in the…

Read News Item

Food safety assessments

November 17, 2022

Problem Formulation in Food Safety Assessments conducted by the European Food Safety Authority RSI investigators recently provided advise to the European Food Safety Authority (EFSA)…

Read News Item

Value of information analysis framework

October 28, 2022

In its 2007 report on Toxicity Testing in the 21st Century: A Vision and a Strategy, the US National Research Council  (NRC) highlighted need for more rapid…

Read News Item